Nova Patents
AT257157T

Compositions containing pyrrolo 2,3-d pyrimidine derivatives

Abstract

Compound formula FORMULA SPACE in R1, R2 and R3 are as defined above, which are enzyme inhibitors sprotein kinases such as Janus kinase 3 and which, as such, are therapeutic agents Useful as immunosuppressive agents for organ transplants, xenotransplantation , lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, type I diabetes and complications due to diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia and other autoimmune diseases.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

106 members in 55 offices

This recordMember, by publication datePriority claim45 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
17017999United States of AmericaP
0001742International Bureau of the World Intellectual Property Organization (WIPO)W

Members106

Family members, oldest first
DocumentOfficeKind
HN2000000265AHondurasA
ECSP003819AEcuadorA
CA2393640A1CanadaA1
DZ3248A1AlgeriaA1
WO0142246A2World Intellectual Property Organization (WIPO)A2
AU1295001AAustraliaA
UY26477A1UruguayA1
PE20011096A1PeruA1
WO0142246A3World Intellectual Property Organization (WIPO)A3
US2001053782A1United States of AmericaA1
PA8507301A1PanamaA1
IS6383AIcelandA
GT200000208AGuatemalaA
NO20022738D0NorwayD0
NO20022738LNorwayL
SV2002000236AEl SalvadorA
KR20020061637ARepublic of KoreaA
BR0016263ABrazilA
MXPA02005675AMexicoA
EP1235830A2European Patent Office (EPO)A2
IL149616D0IsraelD0
EA200200506A1Eurasian Patent Organization (EAPO)A1
BG106855ABulgariaA
TR200201498T2TürkiyeT2
AR026534A1ArgentinaA1
HU0203503A2HungaryA2
HUP0203503A2HungaryA2
CN1409712AChinaA
CO5271665A1ColombiaA1
JP2003516405AJapanA
EE200200304AEstoniaA
CZ20021846A3CzechiaA3
HK1051195A1Hong Kong, ChinaA1
SK7562002A3SlovakiaA3
ZA200204535BSouth AfricaB
US6627754B2United States of AmericaB2
CR6655ACosta RicaA
EP1235830B1European Patent Office (EPO)B1
AT257157TThis recordAustriaT
ATE257157T1AustriaT1
EP1382339A1European Patent Office (EPO)A1
DE60007552D1GermanyD1
TR200400105T4TürkiyeT4
NZ518884ANew ZealandA
US2004053947A1United States of AmericaA1
DK1235830T3DenmarkT3
PT1235830EPortugalE
PL355907A1PolandA1
ES2208433T3SpainT3
SI1235830T1SloveniaT1
HRP20020509A2CroatiaA2
DE60007552T2GermanyT2
AU777911B2AustraliaB2
TW200427453ATaiwan Province of ChinaA
MA26851A1MoroccoA1
HU0203503A3HungaryA3
HUP0203503A3HungaryA3
UA72290C2UkraineC2
YU41302AYugoslavia, later Serbia and Montenegro (until 2006)A
KR100477818B1Republic of KoreaB1
NZ528905ANew ZealandA
GEP20053479BGeorgiaB
CN1195755CChinaC
HRP20020509B1CroatiaB1
US6956041B2United States of AmericaB2
EA006227B1Eurasian Patent Organization (EAPO)B1
TNSN00239A1TunisiaA1
US2005288313A1United States of AmericaA1
TWI248935BTaiwan Province of ChinaB
OA12118AAfrican Intellectual Property Organization (OAPI)A
US7091208B2United States of AmericaB2
CA2393640CCanadaC
TWI264305BTaiwan Province of ChinaB
US2006241131A1United States of AmericaA1
IS2173BIcelandB
NO323378B1NorwayB1
CU23220A3CubaA3
MY130760AMalaysiaA
US7265221B2United States of AmericaB2
EP1382339B1European Patent Office (EPO)B1
AT380031TAustriaT
ATE380031T1AustriaT1
US2007292430A1United States of AmericaA1
DE60037345D1GermanyD1
DK1382339T3DenmarkT3
PT1382339EPortugalE
ES2295495T3SpainT3
JP4078074B2JapanB2
AP1905AAfrican Regional Intellectual Property Organization (ARIPO)A
DE60037345T2GermanyT2
EG24399AEgyptA
US7601727B2United States of AmericaB2
BG65821B1BulgariaB1
SK287188B6SlovakiaB6
US2010035903A1United States of AmericaA1
IL149616AIsraelA
USRE41783EUnited States of AmericaE
EE05351B1EstoniaB1
US7842699B2United States of AmericaB2
RS51574BSerbiaB
Showing 100 of 106